[188 Pages Report] The Antimicrobial Susceptibility Testing Market size was estimated at USD 3.81 billion in 2023 and expected to reach USD 4.02 billion in 2024, at a CAGR 5.83% to reach USD 5.67 billion by 2030.
Antimicrobial susceptibility testing (AST) determines the effectiveness of antibiotics or other antimicrobial drugs against microorganisms such as bacteria, fungi, and viruses. This testing method is an essential tool for guiding the selection of appropriate antibiotics used in treating infectious diseases and monitoring the emergence of drug-resistant strains of microorganisms. The market is experiencing growth due to various factors, including the rising incidence of infectious disorders, the growing adoption of point-of-care testing facilities, and the surging demand for prompt and precise detection of antibiotic resistance. However, challenges affecting the expansion of the AST market comprise high costs associated with advanced technologies such as molecular diagnostics instruments or automated systems, limiting their adoption by small-scale laboratories. In addition, limited access to robust healthcare infrastructure in developing countries, insufficient funding for research and development (R&D), lack of skilled professionals in the field, and variation in regulatory policies among different regions affecting market entry or expansion efforts are the additional obstacles affecting the expansion of the market. Additionally building partnerships between industry stakeholders such as diagnostic manufacturers, healthcare providers researchers and pharmaceutical companies can streamline processes while driving advancements in AST technologies. Moreover, the increasing demand for accurate and timely diagnosis of infectious diseases is expected to create lucrative opportunities for the market, particularly with the technological advancement in disease diagnosis testing techniques and the introduction of new genomic identification methods.
Product Type: Advancement in the automated tools and consumables for early diagnosing and treatment of the infectious diseases
Automated products use various methods such as fluorescence, spectrophotometry, and automated imaging to detect microbial growth and identify the susceptibility of microorganisms to different antibiotics. Manual products include various consumables, such as minimum inhibitory concentration (MIC) strips, susceptibility discs, and susceptibility plates. Manual products are widely used in healthcare facilities, particularly in resource-limited settings where automated systems are not available or cost-effective. Manual testing methods produce accurate results and are an important tool in diagnosing and treating infectious diseases. However, these testing methods are more time-consuming and subjective compared to automated systems.
Method: Development of qualitative AST techniques with increased accuracy of the tests
The disk diffusion method involves placing antibiotic disks onto agar plates inoculated with microorganism testing. The plates are incubated, and the absence or presence of an inhibition zone around the disk is utilized to define the susceptibility or resistance of the microorganism to the antibiotic. The Epsilometer test (ETEST) method involves using a plastic strip containing a gradient of antibiotic concentrations. The minimum inhibitory concentration (MIC) after incubation of the antibiotic is determined by locating the point where the ellipse intersects the strip. Rapid automation method systems use various techniques, including optical detection and impedance measurement, to provide accurate and timely results.
Type: Significant advancements in antifungal susceptibility testing due to heightened awareness of invasive fungal infections
Antimicrobial susceptibility testing is vital in determining effective treatments for microbial infections that focus on antibacterial, antifungal, and antiparasitic susceptibility testing. Antibacterial susceptibility testing is crucial in managing bacterial infections by identifying suitable antibiotics against specific bacterial strains. Additionally, antifungal susceptibility testing guides treatment for fungal infections caused by Candida, Aspergillus, and other pathogenic fungi. Moreover, antiparasitic susceptibility testing determines the effectiveness of antiparasitic drugs against infections caused by parasites such as Plasmodium (malaria), Leishmania, and Trypanosoma species.
Application: Rapid and extreme utilization of the AST in clinical diagnostics and drug discovery and development
AST is widely used in clinical diagnostics to determine the appropriate antibiotic treatment for patients and to identify the effectiveness of antibiotics against a specific microorganism. These diagnostics decrease the risk of treatment failure, reduce the duration of hospitalization, and minimize the development of antibiotic resistance. Moreover, AST is used to evaluate the efficacy of new antibiotics and determine the minimum inhibitory concentration (MIC) of new drugs. In context, this information is valuable in determining the appropriate dosage of the drug and the potential for developing antibiotic resistance.
End-User: Extensive use of AST in hospitals and diagnostic laboratories
Hospitals and diagnostic laboratories use antimicrobial susceptibility testing to diagnose and select treatments accurately. Hospitals and diagnostic laboratories perform antimicrobial testing on various sample types, including blood, urine, and sputum. Pharmaceutical and biotechnology companies use antimicrobial susceptibility testing for drug development processes, as it helps to identify promising candidates for further study.
Regional Insights
The Americas and Europe are significant regions in the global antimicrobial susceptibility testing market due to the rise in infectious diseases and advanced healthcare infrastructure. The Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN), which tracks antimicrobial resistance patterns in nationwide healthcare facilities, promotes AST adoption while ensuring high-quality data collection. In Latin America, significant progress is observed in the field of antimicrobial susceptibility testing (AST), with countries such as Brazil adopting and executing guidelines established by the Clinical & Laboratory Standards Institute (CLSI). This crucial development contributes to the global efforts in combating antimicrobial resistance, thereby ensuring effective treatment options for bacterial infections. Furthermore, the European Centre for Disease Prevention and Control (ECDC) plays a pivotal role in tracking resistance patterns across Europe through its European Antimicrobial Resistance Surveillance Network (EARS-Net). The Asia-Pacific (APAC) is expected to experience substantial growth in the market due to rising awareness about infectious diseases, increasing healthcare expenditure, and emerging drug-resistant microorganisms. China, Japan, and India are the major markets for antimicrobial susceptibility testing within the Asia-Pacific. These nations have a high burden of infectious diseases and a large population, which is expected to drive the demand for AST products and services. Moreover, government initiatives worldwide to control infectious diseases and rising investments & funding in healthcare infrastructure are expected to bolster the market growth in the APAC.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Susceptibility Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Susceptibility Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., Alifax S.r.l., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIOANALYSE T?bbi Malz. San. ve Tic. Ltd. Sti., BioM?rieux SA, Biosafe Ltd., Bruker Corporation, Creative Diagnostics, Danaher Corporation, ELITech Group SAS, Erba Lachema s.r.o., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genefluidics, Inc., Himedia Laboratories Private Limited, INTEGRA Biosciences AG, Laboratorios Conda, S.A., Launch Diagnostics Limited, Leading Biology, Inc., Liofilchem S.r.l., Mast Group Ltd., MP Biomedicals, LLC, Pfizer Inc., Qiagen N.V., QuantaMatrix Inc., Rapid Test Methods Ltd., Resistell AG, Synoptics Group, Thermo Fisher Scientific Inc., and Zhuhai DL Biotech Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product Type
- Automated Products
- Consumables
- Manual Products
- Minimum Inhibitory Concentration (MIC) Strips
- Susceptibility Discs
- Susceptibility Plates
- Method
- Agar Dilution
- Disks Diffusion
- ETEST
- Genotyping Methods
- Rapid Automation Method
- Type
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- End-User
- Contract Research Organizations
- Hospital & Diagnostic Centers
- Pharmaceutical & Biotechnology
- Research & Academic Institutes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Antimicrobial Susceptibility Testing Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Susceptibility Testing Market?
- What are the technology trends and regulatory frameworks in the Antimicrobial Susceptibility Testing Market?
- What is the market share of the leading vendors in the Antimicrobial Susceptibility Testing Market?
- Which modes and strategic moves are suitable for entering the Antimicrobial Susceptibility Testing Market?
US $
Euro €
GBP £